158 related articles for article (PubMed ID: 34026384)
1. Prevalence of Clinical Spectrum of Cutaneous Adverse Drug Reactions in Patients Presenting at a Tertiary Care Hospital in Pakistan.
Hina A; Masood S; Jamil S; Tabassum S; Jalil P; Ghulam U
Cureus; 2021 Apr; 13(4):e14568. PubMed ID: 34026384
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Cutaneous Adverse Drug Reactions (ADR) Reported at an ADR Monitoring Center of a Tertiary Care Teaching Institute in Central India.
Chindhalore CA; Gupta AV; Dakhale GN; Srivastava A
Cureus; 2024 Feb; 16(2):e53706. PubMed ID: 38455795
[TBL] [Abstract][Full Text] [Related]
3. A Study of Cutaneous Adverse Drug Reactions at a Tertiary Care Center in Andhra Pradesh, India.
Ashifha S; Vijayashree J; Vudayana K; Chintada D; P P; G P; Unnikrishnan P
Cureus; 2023 Apr; 15(4):e37596. PubMed ID: 37197134
[TBL] [Abstract][Full Text] [Related]
4. Nevirapine: Most Common Cause of Cutaneous Adverse Drug Reactions in an Outpatient Department of a Tertiary Care Hospital.
Pawar MP; Pore SM; Pradhan SN; Burute SR; Bhoi UY; Ramanand SJ
J Clin Diagn Res; 2015 Nov; 9(11):FC17-20. PubMed ID: 26672558
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous adverse drug reactions in Indian population: A systematic review.
Patel TK; Thakkar SH; Sharma D
Indian Dermatol Online J; 2014 Dec; 5(Suppl 2):S76-86. PubMed ID: 25593813
[TBL] [Abstract][Full Text] [Related]
6. Trends in culprit drugs and clinical entities in cutaneous adverse drug reactions: a retrospective study.
Wang F; Zhao YK; Li M; Zhu Z; Zhang X
Cutan Ocul Toxicol; 2017 Dec; 36(4):370-376. PubMed ID: 28423957
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous Adverse Drug Reactions in a Tertiary Care Teaching Hospital in India: An Intensive Monitoring Study.
Thakkar S; Patel TK; Vahora R; Bhabhor P; Patel R
Indian J Dermatol; 2017; 62(6):618-625. PubMed ID: 29263536
[TBL] [Abstract][Full Text] [Related]
8. Pharmacovigilance of Cutaneous Adverse Drug Reactions among Patients Attending Dermatology Department at a Tertiary Care Hospital.
Sharma S; Jayakumar D; Palappallil DS
Indian Dermatol Online J; 2019; 10(5):547-554. PubMed ID: 31544074
[TBL] [Abstract][Full Text] [Related]
9. A Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Center in Punjab.
Jha N; Alexander E; Kanish B; Badyal DK
Indian Dermatol Online J; 2018; 9(5):299-303. PubMed ID: 30258795
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
Ding WY; Lee CK; Choon SE
Int J Dermatol; 2010 Jul; 49(7):834-41. PubMed ID: 20618508
[TBL] [Abstract][Full Text] [Related]
11. A Clinico-Epidemiological Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Centre of Eastern India.
Sinha S; Kar C; Das S; Dutta A; De A
Indian J Dermatol; 2024; 69(1):106. PubMed ID: 38572036
[TBL] [Abstract][Full Text] [Related]
12. Morphological Pattern of Cutaneous Adverse Drug Reactions due to Antiepileptic Drugs in Eastern India.
Singh PK; Kumar MK; Kumar D; Kumar P
J Clin Diagn Res; 2015 Jan; 9(1):WC01-3. PubMed ID: 25738068
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous adverse drug reactions notified by pharmacovigilance in a tertiary care hospital in north India.
Mittal N; Gupta M; Singla M
Cutan Ocul Toxicol; 2014 Dec; 33(4):289-93. PubMed ID: 24517496
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous adverse drug reactions in a tertiary care teaching hospital: A North Indian perspective.
Nandha R; Gupta A; Hashmi A
Int J Appl Basic Med Res; 2011 Jan; 1(1):50-3. PubMed ID: 23776774
[TBL] [Abstract][Full Text] [Related]
15. Association of HLA-A*31:01 Screening With the Incidence of Carbamazepine-Induced Cutaneous Adverse Reactions in a Japanese Population.
Mushiroda T; Takahashi Y; Onuma T; Yamamoto Y; Kamei T; Hoshida T; Takeuchi K; Otsuka K; Okazaki M; Watanabe M; Kanemoto K; Oshima T; Watanabe A; Minami S; Saito K; Tanii H; Shimo Y; Hara M; Saitoh S; Kinoshita T; Kato M; Yamada N; Akamatsu N; Fukuchi T; Ishida S; Yasumoto S; Takahashi A; Ozeki T; Furuta T; Saito Y; Izumida N; Kano Y; Shiohara T; Kubo M;
JAMA Neurol; 2018 Jul; 75(7):842-849. PubMed ID: 29610831
[TBL] [Abstract][Full Text] [Related]
16. Ciprofloxacin-induced cutaneous adverse drug events: a systematic review of descriptive studies.
Kashyap A; Sreenivasan S; Rajan AK; Rashid M; Chhabra M
J Basic Clin Physiol Pharmacol; 2021 Mar; 33(3):327-346. PubMed ID: 33725760
[TBL] [Abstract][Full Text] [Related]
17. Retrospective Analysis of Pattern of Cutaneous Adverse Drug Reactions in Tertiary Hospital of Pauri Garhwal.
Dimri D; Raina RS; Thapliyal S; Thawani V
J Clin Diagn Res; 2016 May; 10(5):FC01-6. PubMed ID: 27437240
[TBL] [Abstract][Full Text] [Related]
18. Adverse cutaneous drug reactions among hospitalized patients: five year surveillance.
Turk BG; Gunaydin A; Ertam I; Ozturk G
Cutan Ocul Toxicol; 2013 Mar; 32(1):41-5. PubMed ID: 22812902
[TBL] [Abstract][Full Text] [Related]
19. Frequency of Hyponatremia in Patients of Tuberculosis Bacterial Meningitis in a Tertiary Care Hospital.
Kumar A; Singh J; Hashmat O; Ameet P; Budhrani N; Sher K
Cureus; 2021 Mar; 13(3):e13888. PubMed ID: 33868852
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous adverse drug reactions: a 9-year study from a South Indian Hospital.
Sushma M; Noel MV; Ritika MC; James J; Guido S
Pharmacoepidemiol Drug Saf; 2005 Aug; 14(8):567-70. PubMed ID: 15937869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
